Literature DB >> 16107146

Synthesis, DNA affinity, and antiprotozoal activity of fused ring dicationic compounds and their prodrugs.

Reem K Arafa1, Reto Brun, Tanja Wenzler, Farial A Tanious, W David Wilson, Chad E Stephens, David W Boykin.   

Abstract

Dicationic guanidine, N-alkylguanidine, and reversed amidine derivatives of fused ring systems have been synthesized from their corresponding bis-amines. DNA binding studies suggest that the diguanidines and the N-alkyl diguanidines fluorenes bind in the minor groove in a manner similar to that of the previously reported dicationic carbazole derivatives. The diguanidines and the N-alkyl diguanidines showed promising in vitro activity against both Trypanosoma brucei rhodesiense and Plasmodium falciparum. Promising in vivo biological results were obtained for the dicationic N-isopropylguanidino-9H-fluorene, giving 4/4 cures of the treated animals in the STIB900 animal model for African trypanosomiasis. The N-methyl analogue showed high activity as well. In addition, with the goal of enhancing the oral bioavailability, two novel classes of potential guanidine prodrugs were prepared. The N-alkoxyguanidine derivatives were not effective as prodrugs. In contrast, a number of the carbamates showed promising activity. The value of the carbamate prodrugs was clearly demonstrated by the results, which gave 4/4 cures on oral administration in the STIB900 mouse model.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16107146     DOI: 10.1021/jm058190h

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  The trypanocidal activity of amidine compounds does not correlate with their binding affinity to Trypanosoma cruzi kinetoplast DNA.

Authors:  A Daliry; M Q Pires; C F Silva; R S Pacheco; M Munde; C E Stephens; A Kumar; M A Ismail; Z Liu; A A Farahat; S Akay; P Som; Q Hu; D W Boykin; W D Wilson; S L De Castro; M N C Soeiro
Journal:  Antimicrob Agents Chemother       Date:  2011-08-01       Impact factor: 5.191

2.  Molecular factors governing inhibition of arylimidamides against Leishmania: conservative computational modeling to improve chemotherapies.

Authors:  Catharine J Collar; Xiaohua Zhu; Karl Werbovetz; David W Boykin; W David Wilson
Journal:  Bioorg Med Chem       Date:  2011-06-16       Impact factor: 3.641

3.  A new nonpolar N-hydroxy imidazoline lead compound with improved activity in a murine model of late-stage Trypanosoma brucei brucei infection is not cross-resistant with diamidines.

Authors:  Carlos H Ríos Martínez; Florence Miller; Kayathiri Ganeshamoorthy; Fabienne Glacial; Marcel Kaiser; Harry P de Koning; Anthonius A Eze; Laura Lagartera; Tomás Herraiz; Christophe Dardonville
Journal:  Antimicrob Agents Chemother       Date:  2014-11-24       Impact factor: 5.191

4.  Novel linear triaryl guanidines, N-substituted guanidines and potential prodrugs as antiprotozoal agents.

Authors:  Reem K Arafa; Mohamed A Ismail; Manoj Munde; W David Wilson; Tanja Wenzler; Reto Brun; David W Boykin
Journal:  Eur J Med Chem       Date:  2008-02-29       Impact factor: 6.514

5.  Enhancing the intestinal absorption of molecules containing the polar guanidino functionality: a double-targeted prodrug approach.

Authors:  Jing Sun; Arik Dahan; Gordon L Amidon
Journal:  J Med Chem       Date:  2010-01-28       Impact factor: 7.446

6.  Carbon-hydrogen bond functionalization approach for the synthesis of fluorenones and ortho-arylated benzonitriles.

Authors:  Dmitry Shabashov; Jesús R Molina Maldonado; Olafs Daugulis
Journal:  J Org Chem       Date:  2008-09-03       Impact factor: 4.354

Review 7.  Novel amidines and analogues as promising agents against intracellular parasites: a systematic review.

Authors:  M N C Soeiro; K Werbovetz; D W Boykin; W D Wilson; M Z Wang; A Hemphill
Journal:  Parasitology       Date:  2013-04-08       Impact factor: 3.234

8.  Induced fit conformational changes of a "reversed amidine" heterocycle: optimized interactions in a DNA minor groove complex.

Authors:  Manoj Munde; Michael Lee; Stephen Neidle; Reem Arafa; David W Boykin; Yang Liu; Christian Bailly; W David Wilson
Journal:  J Am Chem Soc       Date:  2007-04-11       Impact factor: 15.419

9.  In silico identification of inhibitors against Plasmodium falciparum histone deacetylase 1 (PfHDAC-1).

Authors:  Amarjeet Kumar; Suman Kumar Dhar; Naidu Subbarao
Journal:  J Mol Model       Date:  2018-08-14       Impact factor: 1.810

10.  Neglected disease - african sleeping sickness: recent synthetic and modeling advances.

Authors:  Sarvesh K Paliwal; Ankita Narayan Verma; Shailendra Paliwal
Journal:  Sci Pharm       Date:  2011-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.